SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Interim Management Statement

25 Jul 2013 07:00

RNS Number : 0479K
Victrex PLC
25 July 2013
 



25 July 2013

Victrex plc - Interim Management Statement

 

'Trading in line with expectations'

 

Victrex plc ('Victrex'), an innovative world leader in high performance thermoplastic polymers, today releases its third quarter Interim Management Statement, covering the period from 1 April 2013 to date.

 

The Company continues to trade in line with market expectations, despite on-going uncertainty in the wider global economy. Group sales volume in the third quarter was 756 tonnes, in line with the previous financial year (Q3 2012: 754 tonnes). Trading in our Invibio Biomaterials business since the half year has been reassuring, with revenue in Q3 ahead of the same period last year.

 

Looking forward, initial order patterns in the fourth quarter across both of our business units continue to be in line with our expectations. There have been no significant changes in the financial position of the Company since it reported its interim results on 28 May 2013.

 

Victrex will host an Investor Day in London on 10 October 2013. Presentations by senior management will focus on strategy and the growth opportunities being developed throughout the Group.

 

Victrex will release its pre-close trading update on 8 October 2013, which will cover the period ending 30 September 2013.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations

Steve Barrow, Group Finance Director

 

01253 898121

01253 897700

 

MHP Communications:

Nick Denton/Barnaby Fry/Ian Payne

 

 

0203 128 8100

 

Investor and analyst call:

A conference call for investors

and analysts will be held today, 25 July 2013 at 09.00am UK time. For more information please contact Rosa Smith at MHP Communications on 0203 128 8560.

 

About Victrex:

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic. With over 30 years of experience, we serve customers across a range of industries, from aerospace, automotive and electronics, to medical and oil and gas, delivering technology driven solutions to the challenges and opportunities they face.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAEXLADPDEFF
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.